LC-MS is currently the ‘go to’ method for small molecule bioanalysis due to its sensitivity, selectivity, dynamic range, and robustness. It is also increasingly used for the analysis of biopharmaceuticals. LC-MS analysis is constantly developing alongside technological advancements such as HRMS, microflow LC, and DBS.
Current trends in LC-MS, insights, and advice from leading industry experts are explored as part of Bioanalysis Zone's Spotlight on LC-MS.
Webinar: The Ever-Expanding Role of HRMS in Regulated Bioanalysis: Application to Both Small Molecule and Biopharmaceutical Study Support, presented by Christopher A Evans, Director, Bioanalytical Sciences and Toxicokinetics, PTS-DMPK, GlaxoSmithKline. Watch on-demand:
Panel Discussion: Expert panelists give advice on aspects such as how to improve throughput and accuracy in your LC-MS assays. Watch on-demand:
Related HRMS Resources
Application Note: High Sensitivity Intact Mass Analysis of Antibodies (IgG1) Using ionKey/MS. Download Now
Seminar: Development of High Sensitivity Intact Monoclonal Antibody (mAb) Analysis Using an Intergrated Microfluidics MS System. Watch Now
Interview: Mark Wrona, Senior Science Manager at Waters Corporation, on challenges and capabilities
of LC-MS. Read Now
Interview: Mary Lame, Senior Applications Chemist, at Waters Corporation, about her perspective and recent developments in LC-MS. Read Now.